Spontaneous evolution of human papillomavirus infection in the uterine cervix

Anticancer Research

Volumn 19, Issue 4 C, 1999, Pages 3473-3478

  Paraskevaidis, Evangelos ^b   Kalantaridou, Sophia N ^c   Georgiou, Ioannis ^c   Koliopoulos, George ^c   Pappa, Lina ^c   Malamou Mitsi, Vassiliki ^c   Agnantis, Niki J ^c   Kitchener, Henry C ^a   Lolis, Dimitrios E ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c NONE

Author keywords

Cervical intraepithelial neoplasia; Colposcopy; Cytology; Human papillomavirus typing; Low grade squamous intraepithelial lesion

Indexed keywords

VIRUS DNA;

ARTICLE; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 0033428957     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Park TW, Fujiwara H and Wright TC: Molecular biology of cervical cancer and its precursors. Cancer 76: 1902-1913, 1995.
2. McIndoe WA, McLean MR, Jones RN and Mullins PR: The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 64: 451-459, 1984.
3. Ferenczy A and Jenson AB: Tissue effects and host response. The key to the rational triage of cervical neoplasia. Obstet Gynecol Clin N Am 23: 759-782, 1996.
4. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R, Hong WK and Schottenfeld D: Cervical human papillomavirus infection and intraepithelial neoplasia: a review. Monogr Natl Cancer Inst 21: 17-25, 1996.
5. Zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13, 1991.
6. Scheffner M, Munger K, Byrne JC and Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88: 5523-5527, 1991.
7. Fairley CK, Chen S, Ugoni A, Tabrizi SN, Forbes A and Garland SM: Human papillomavirus infection and its relationship to recent and distant sexual partners. Obstet Gynecol 84: 755-759, 1994.
8. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A and Manos MM: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265: 472-477, 1991.
9. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M and Bierman R: Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 174: 679-689, 1996.
10. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E and Wadell G: Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 71: 1026-1030, 1995.
11. Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, Rylander E and Wadell G: Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 22: 119-127, 1995.
12. Ho GYF, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervical papillomavirus infection in young women. N Engl J Med 338: 423-428, 1998.
13. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E and Patefsky J: The natural history of human papillomavirus infection as measured by repeat DNA testing in adolescent and young women. J Pediatr 132: 277-284, 1998.
14. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. Acta Cytol 36: 273-276, 1992.
15. Resnick RM, Comelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J and Manos MM: Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 82: 1477-1484, 1990.
16. Hatch KD, Schneider A and Abdel-Nour MW: An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol 172: 1150-1157, 1995.
17. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST and Guillebaud J: Human papillomavirus testing in primaly cervical screening. Lancet 345: 1533 1536, 1995.
18. Cox TJ, Schiffman MH, Winzelherg AJ and Patterson JM: An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol 80: 389-395, 1992.
19. Nyirjesy I, Billingsley FS and Forman MR: Evaluation of atypical and low-grade cervical cytology in private practice. Obstet Gynecol 92: 601-007, 1998.
20. Kaufman RH, Adam E, Icenogle J, Lawson H, Lee N, Reeves KO, Irwin J, Simon T, Press M, Uhler R, Entman C and Reeves WC: Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 176: 87-92, 1997.
21. Kaufman RH, Adam E, Icenogle J and Reeves WC: Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: Sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol 177: 930-936, 1997.
22. Adam E, Kaufman RH, Berkova Z, Icenogle J and Reeves WC: Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 178: 1235-1244, 1998.
23. Monsonego J, Valensi P, Zerat L, Clavel C and Birembaut P: Simultaneous effect of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia. Br J Obstet Gynaecol 104: 723-727, 1997.
24. Downey GP, Bavin PJ, Deery ARS, Crow J, Grifffiths PD, Emery VC and Walka PG: Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet 344: 432-435, 1994.
25. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM and Manos MM: Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 88: 261-268, 1996.
26. Tate JE, Resnick M, Sheets EE and Crum CP: Absence of papillomavirus DNA in normal tissue adjacent to most cervical intraepithelial neoplasms. Obstet Gynecol 88: 257-260, 1996.
27. Campion MJ, McCance DJ, Cuzick J and Singer A: Progressive potential of mild cervical atypia: a prospective cytological, colposcopic and virological study. Lancet ii: 237-240, 1986.
28. Richart RM and Wright TC: Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer 71: 1413-1421, 1993.
29. Remnick AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, Meijer CJ and Kenemans P: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311, 1995.
30. Kotloff KL, Wasserman SS, Russ K, Shapiro S, Daniel R, Brown W, Frost A, Tabara SO and Shah K: Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 25: 243-250, 1998.